Syntar Eye Drops

Dry eye, Burning, and irritation of the eye

Eye Drop 1 drop 4 times daily or as required, depending upon the severity of the disease, to be instilled into the conjunctival sac.

Eye Drops is contraindicated in patients with known hypersensitivity to any ingredient of the product.

Patients who experience blurred vision after application of the product should not drive or use machinery until their vision has cleared. Contact lenses should not be worn during instillation of the product. After instillation there should be an interval of at least 30 minutes before reinsertion of contact lenses.

C

Enzyme inducers e.g. phenytoin or carbamazepine and enzyme inhibitors e.g. cimetidine. Sodium Chloride: May affect serum concentrations of lithium.

Occasionally mild-transient burning or sticky sensation and very rarely irritation or hypersensitivity reactions reported. Blurred vision after application may occur.

Dextrans produce expansion of plasma volume. It also reduces blood viscosity and inhibits sludging or aggregation of red blood cells.

Syntar 0.1% + 0.3% Eye Drops manufactured by Drug International Ltd.. Its generic name is Dextran 70 + Hypromellose Eye prep.